1149336 Ontario, Inc.
Patent Owner
Stats
- 22 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 07, 2016 most recent publication
Details
- 22 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,072 Total Citation Count
- Apr 14, 1995 Earliest Filing
- 13 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9044424 Methods of regulating glucose metabolism, and reagents related theretoJul 25, 13Jun 02, 15[A61K]
8513190 Method of regulating glucose metabolism, and reagents related theretoNov 16, 11Aug 20, 13[A61K]
8318669 Method of regulating glucose metabolism, and reagents related theretoNov 09, 10Nov 27, 12[A61K]
7829530 Method of regulating glucose metabolism, and reagents related theretoNov 26, 08Nov 09, 10[A61K]
7459428 Method of regulating glucose metabolism, and reagents related theretoJul 17, 06Dec 02, 08[A61K]
7157429 Method of regulating glucose metabolism, and reagents related theretoJul 28, 00Jan 02, 07[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0000,857 Method of Regulating Glucose Metabolism, and Reagents Related TheretoAbandonedMay 13, 15Jan 07, 16[A61K]
2014/0213,518 METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINEAbandonedNov 05, 13Jul 31, 14[C07K]
8603976 Methods of enhancing functioning of the large intestineExpiredAug 30, 12Dec 10, 13[A61K, A61P]
8278273 Methods of enhancing functioning of the large intestineExpiredMay 06, 11Oct 02, 12[A61K, G01N]
2011/0223,108 GLUCAGON-LIKE PEPTIDE-2 AND ITS THERAPEUTIC USEAbandonedDec 22, 10Sep 15, 11[A61K, A61P, C07K]
2004/0132,025 Ampk-related serine/threonine kinase, designated snarkAbandonedJul 02, 03Jul 08, 04[C07H, C12Q, C12N]
2003/0109,449 Antagonists of intestinotrophic GLP-2 peptidesAbandonedNov 18, 02Jun 12, 03[A61K, G01N, C07K]
2002/0045,173 GLP-2 receptor gene promoter and uses thereofAbandonedApr 13, 01Apr 18, 02[C07H, C12Q, C12P, C12N, A01K, C07K]
5846937 Method of using exendin and GLP-1 to affect the central nervous systemExpiredMar 03, 97Dec 08, 98[A61K, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
